In this issue:
- ASPEN: brensocatib (DPP-1 inhibitor) in bronchiectasis
- SAVE-BE: HSK31858 (DPP-1 inhibitor) in bronchiectasis
- Role of IL-1β in bronchiectasis pathophysiology
- Carbocisteine and hypertonic saline in bronchiectasis
- Gremubamab to enhance neutrophil-mediated killing of P. aeruginosa in bronchiectasis
- Cardiovascular benefits of macrolide maintenance therapy in bronchiectasis
- SKYLINE: vanzacaftor tezacaftor-deutivacaftor vs. elexacaftor-tezacaftor ivacaftor in cystic fibrosis
- Maternal outcomes with CFTR modulators in pregnancy
- VX19-445-107: long-term elexacaftor/tezacaftor/ ivacaftor in children with cystic fibrosis and ≥1 F508del allele
- SOOTHE: camlipixant in refractory chronic cough
Please login below to download this issue (PDF)